|
US2020353233A1
|
|
Non-digestible, controlled release system for soluble drug delivery
|
|
WO2017100480A1
|
|
Apparatus and method for detecting and/or monitoring one or more compounds in blood
|
|
US2016113561A1
|
|
Apparatus and method for detecting and/or monitoring one or more compounds in blood
|
|
WO2016044645A1
|
|
Anticoagulant derivatives for cardiovascular imaging
|
|
US2016135235A1
|
|
System and method for information sharing based on wireless association
|
|
US2015190594A1
|
|
Dry-powder inhalation device
|
|
US2014243636A1
|
|
Apparatus and method for detecting and\or monitoring one or more compounds in blood
|
|
US2014200653A1
|
|
Material structures for intravascular device
|
|
HK1168021A1
|
|
Delivery system for intravascular device with netting
|
|
US2013024883A1
|
|
System and method for access over a cable television network
|
|
US2012195295A1
|
|
System and method for identification of mobile device users in an area of a wireless access point
|
|
US2010208681A1
|
|
Infrastructure for wireless telecommunication networks
|
|
US2010215578A1
|
|
Catalytic radiofluorination
|
|
CA2748998A1
|
|
Delivery system for intravascular device with netting
|
|
US2011060138A1
|
|
Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders
|
|
WO2010021616A1
|
|
Reducing global warming
|
|
US2010040504A1
|
|
Reducing global warming
|
|
WO2008134618A2
|
|
Novel imaging tracers for early detection and treatment of amyloid plaques caused by alzheimer's disease and related disorders
|
|
US2012207677A1
|
|
Catalytic radiofluorination
|
|
US2009220433A1
|
|
Biotinylated compositions
|
